Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2022 Filed Mar 14, 2022 20:22 UTC |
Patterson ChadEVP, Global Marketing
|
SaleCommon Stock | 776 | $401.27 | $311,385.52 |
DisclosureSEC source: 0001093557-22-000061 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,228 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:21 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
SaleCommon Stock | 2,366 | $401.27 | $949,404.82 |
DisclosureSEC source: 0001093557-22-000060 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,454 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Stern SadieEVP Chief Human Resources Off
|
Disposition to issuerCommon Stock | 701 | $406.06 | $284,645.75 |
DisclosureSEC source: 0001093557-22-000056 · edgardoc.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,057 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 16,880 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:31 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
Disposition to issuerCommon Stock | 192 | $406.06 | $77,962.89 |
DisclosureSEC source: 0001093557-22-000057 · edgardoc.xml · nonDerivative · entry 5 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,008 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,583 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:31 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
Disposition to issuerCommon Stock | 424 | $406.06 | $172,168.04 |
DisclosureSEC source: 0001093557-22-000057 · edgardoc.xml · nonDerivative · entry 4 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,200 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,583 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:31 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
Disposition to issuerCommon Stock | 844 | $406.06 | $342,711.85 |
DisclosureSEC source: 0001093557-22-000057 · edgardoc.xml · nonDerivative · entry 3 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,624 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,583 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:31 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
Disposition to issuerCommon Stock | 491 | $406.06 | $199,373.84 |
DisclosureSEC source: 0001093557-22-000057 · edgardoc.xml · nonDerivative · entry 2 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,468 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,583 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
Disposition to issuerCommon Stock | 337 | $406.06 | $136,841.11 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 5 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,789 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
Disposition to issuerCommon Stock | 309 | $406.06 | $125,471.52 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 4 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,126 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
Disposition to issuerCommon Stock | 192 | $406.06 | $77,962.89 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 3 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,435 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
Disposition to issuerCommon Stock | 519 | $406.06 | $210,743.43 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,627 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
Disposition to issuerCommon Stock | 805 | $406.06 | $326,875.64 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 4 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,820 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
Disposition to issuerCommon Stock | 541 | $406.06 | $219,676.67 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,625 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
Disposition to issuerCommon Stock | 519 | $406.06 | $210,743.43 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,166 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Regan Barry J.EVP Global Operations
|
Disposition to issuerCommon Stock | 661 | $406.06 | $268,403.48 |
DisclosureSEC source: 0001093557-22-000052 · edgardoc.xml · nonDerivative · entry 2 Regan Barry J. · CIK 0001746313 · EVP Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,451 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:28 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
Disposition to issuerCommon Stock | 2,363 | $406.06 | $959,511.98 |
DisclosureSEC source: 0001093557-22-000053 · edgardoc.xml · nonDerivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,883 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 33,698 unvested restricted stock units, 16,251 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,963 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:28 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
Disposition to issuerCommon Stock | 4,473 | $406.06 | $1,816,291.62 |
DisclosureSEC source: 0001093557-22-000053 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,246 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 33,698 unvested restricted stock units, 16,251 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,963 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:28 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
Disposition to issuerCommon Stock | 3,149 | $406.06 | $1,278,672.55 |
DisclosureSEC source: 0001093557-22-000053 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,719 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 33,698 unvested restricted stock units, 16,251 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,963 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Patterson ChadEVP, Global Marketing
|
Disposition to issuerCommon Stock | 974 | $406.06 | $395,499.23 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 5 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,004 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Patterson ChadEVP, Global Marketing
|
Disposition to issuerCommon Stock | 223 | $406.06 | $90,550.64 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 4 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,978 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Patterson ChadEVP, Global Marketing
|
Disposition to issuerCommon Stock | 432 | $406.06 | $175,416.49 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 3 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,201 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Patterson ChadEVP, Global Marketing
|
Disposition to issuerCommon Stock | 192 | $406.06 | $77,962.89 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,633 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
Disposition to issuerCommon Stock | 1,180 | $406.06 | $479,146.91 |
DisclosureSEC source: 0001093557-22-000050 · edgardoc.xml · nonDerivative · entry 4 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,925 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
Disposition to issuerCommon Stock | 932 | $406.06 | $378,444.84 |
DisclosureSEC source: 0001093557-22-000050 · edgardoc.xml · nonDerivative · entry 3 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,105 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
Disposition to issuerCommon Stock | 1,317 | $406.06 | $534,776.67 |
DisclosureSEC source: 0001093557-22-000050 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,037 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:25 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
Disposition to issuerCommon Stock | 891 | $406.06 | $361,796.52 |
DisclosureSEC source: 0001093557-22-000049 · edgardoc.xml · nonDerivative · entry 4 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,746 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 18,362 unvested restricted stock units, 6,741 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 4,780 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:25 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
Disposition to issuerCommon Stock | 2,065 | $406.06 | $838,507.09 |
DisclosureSEC source: 0001093557-22-000049 · edgardoc.xml · nonDerivative · entry 3 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,637 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 18,362 unvested restricted stock units, 6,741 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 4,780 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:25 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
Disposition to issuerCommon Stock | 1,317 | $406.06 | $534,776.67 |
DisclosureSEC source: 0001093557-22-000049 · edgardoc.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,702 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 18,362 unvested restricted stock units, 6,741 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 4,780 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Flynn Paul REVP Global Revenue
|
Disposition to issuerCommon Stock | 784 | $406.06 | $318,348.45 |
DisclosureSEC source: 0001093557-22-000048 · edgardoc.xml · nonDerivative · entry 4 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,183 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,936 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,958 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Flynn Paul REVP Global Revenue
|
Disposition to issuerCommon Stock | 1,114 | $406.06 | $452,347.16 |
DisclosureSEC source: 0001093557-22-000048 · edgardoc.xml · nonDerivative · entry 3 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,967 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,936 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,958 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Flynn Paul REVP Global Revenue
|
Disposition to issuerCommon Stock | 1,069 | $406.06 | $434,074.61 |
DisclosureSEC source: 0001093557-22-000048 · edgardoc.xml · nonDerivative · entry 2 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,081 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,936 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,958 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Dolan Matthew VincentSVP Corporate Development
|
Disposition to issuerCommon Stock | 541 | $406.06 | $219,676.67 |
DisclosureSEC source: 0001093557-22-000047 · edgardoc.xml · nonDerivative · entry 5 Dolan Matthew Vincent · CIK 0001914994 · SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,820 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Dolan Matthew VincentSVP Corporate Development
|
Disposition to issuerCommon Stock | 489 | $406.06 | $198,561.73 |
DisclosureSEC source: 0001093557-22-000047 · edgardoc.xml · nonDerivative · entry 4 Dolan Matthew Vincent · CIK 0001914994 · SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,361 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Dolan Matthew VincentSVP Corporate Development
|
Disposition to issuerCommon Stock | 192 | $406.06 | $77,962.89 |
DisclosureSEC source: 0001093557-22-000047 · edgardoc.xml · nonDerivative · entry 3 Dolan Matthew Vincent · CIK 0001914994 · SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,850 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:24 UTC |
Dolan Matthew VincentSVP Corporate Development
|
Disposition to issuerCommon Stock | 393 | $406.06 | $159,580.28 |
DisclosureSEC source: 0001093557-22-000047 · edgardoc.xml · nonDerivative · entry 2 Dolan Matthew Vincent · CIK 0001914994 · SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,042 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:21 UTC |
Abbey DonaldEVP Quality Regulatory Affairs
|
Disposition to issuerCommon Stock | 1,180 | $406.06 | $479,146.91 |
DisclosureSEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 4 Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,229 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:21 UTC |
Abbey DonaldEVP Quality Regulatory Affairs
|
Disposition to issuerCommon Stock | 932 | $406.06 | $378,444.84 |
DisclosureSEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 3 Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,409 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:21 UTC |
Abbey DonaldEVP Quality Regulatory Affairs
|
Disposition to issuerCommon Stock | 1,317 | $406.06 | $534,776.67 |
DisclosureSEC source: 0001093557-22-000044 · edgardoc.xml · nonDerivative · entry 2 Abbey Donald · CIK 0001534342 · EVP Quality Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,341 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:22 UTC |
Balo Andrew KEVP, Global Medical Affairs
|
Disposition to issuerCommon Stock | 949 | $406.06 | $385,347.81 |
DisclosureSEC source: 0001093557-22-000045 · edgardoc.xml · nonDerivative · entry 4 Balo Andrew K · CIK 0001323190 · EVP, Global Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,615 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:22 UTC |
Balo Andrew KEVP, Global Medical Affairs
|
Disposition to issuerCommon Stock | 1,549 | $406.06 | $628,981.83 |
DisclosureSEC source: 0001093557-22-000045 · edgardoc.xml · nonDerivative · entry 3 Balo Andrew K · CIK 0001323190 · EVP, Global Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,564 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:22 UTC |
Balo Andrew KEVP, Global Medical Affairs
|
Disposition to issuerCommon Stock | 932 | $406.06 | $378,444.84 |
DisclosureSEC source: 0001093557-22-000045 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Global Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,113 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:30 UTC |
Stern SadieEVP Chief Human Resources Off
|
GrantCommon Stock | 5,297 | $0.00 | $5.30 |
DisclosureSEC source: 0001093557-22-000056 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,758 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 16,880 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:31 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
GrantCommon Stock | 5,297 | $0.00 | $5.30 |
DisclosureSEC source: 0001093557-22-000057 · edgardoc.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,959 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 13,583 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:30 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
GrantCommon Stock | 2,889 | $0.00 | $2.89 |
DisclosureSEC source: 0001093557-22-000055 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,146 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 6,373 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,436 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:30 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
GrantCommon Stock | 2,889 | $0.00 | $2.89 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,685 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:27 UTC |
Regan Barry J.EVP Global Operations
|
GrantCommon Stock | 4,984 | $0.00 | $4.98 |
DisclosureSEC source: 0001093557-22-000052 · edgardoc.xml · nonDerivative · entry 1 Regan Barry J. · CIK 0001746313 · EVP Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,112 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:28 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
GrantCommon Stock | 16,251 | $0.00 | $16.25 |
DisclosureSEC source: 0001093557-22-000053 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,868 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 33,698 unvested restricted stock units, 16,251 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,963 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:27 UTC |
Patterson ChadEVP, Global Marketing
|
GrantCommon Stock | 5,297 | $0.00 | $5.30 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,825 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:27 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
GrantCommon Stock | 4,984 | $0.00 | $4.98 |
DisclosureSEC source: 0001093557-22-000050 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,354 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:25 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
GrantCommon Stock | 6,741 | $0.00 | $6.74 |
DisclosureSEC source: 0001093557-22-000049 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,019 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 18,362 unvested restricted stock units, 6,741 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 4,780 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.